ea0056p478 | Diabetes therapy | ECE2018
Benderradji Hamza
, Kwapich Maxime
, Bouzaib Samira
, Ythier Hubert
, Zephir Helene
, Leroy Clara
Introduction: Type 1 diabetes (T1D) and multiple sclerosis (MS) are autoimmune diseases with common immunological mechanisms. Type 1 diabetics have an increased risk of MS. The aim of this work is to report a clinical observation of a partial preservation of β-cell function in a type 1 diabetic patient treated early by Fingolimod for MS.Observation: A polyuro-polydipsic syndrome and a weight loss of 10 kg led to the diagnosis of T1D (typing HLA DR4/...